2-METHYL-N-(3-METHYL-4-((2,3,4,5-TETRAHYDRO-5-OXO-1H-1-BENZAZEPIN-1-YL)CARBONYL)PHENYL)BENZAMIDE
UNII XRK4B36PZK
Substance Identification & Data
This profile provides standardized clinical and technical data for 2-methyl-n-(3-methyl-4-((2,3,4,5-tetrahydro-5-oxo-1h-1-benzazepin-1-yl)carbonyl)phenyl)benzamide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) XRK4B36PZK.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 137977-65-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C26H24N2O3 FAUPREOAYVDTPK-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 2-methyl-n-(3-methyl-4-((2,3,4,5-tetrahydro-5-oxo-1h-1-benzazepin-1-yl)carbonyl)phenyl)benzamide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.